Tag: clinical trials

Viz.ai and Vastrax join forces to accelerate neurovascular clinical trial enrolment

Viz.ai has announced a strategic partnership with full-service, vascular clinical research organisation (CRO) Vastrax. Together, the two companies intend to accelerate clinical trial enrolment for...

Research indicates low stroke risk and benefit of medication alone in...

The risk of having a future stroke caused by asymptomatic carotid stenosis is “so low” that most patients with this condition could potentially be...

PathMaker initiates US multicentre trial evaluating non-invasive post-stroke spasticity treatment

PathMaker Neurosystems has announced initiation of its US multicentre clinical trial to evaluate MyoRegulator for the non-invasive treatment of post-stroke upper-limb spasticity. The trial is...

FDA issues two final guidances for including patient perspectives in medical...

The US Food and Drug Administration (FDA) has issued two final guidances providing recommendations for including patient perspectives in medical device clinical studies.   As...
saint depression treatment

Novel neuromodulation technique could be “gamechanger” in treatment-resistant depression

Stanford accelerated intelligent neuromodulation therapy (SAINT)—a novel, high-dose intermittent theta-burst stimulation (iTBS)—was found to be safe and more effective than sham stimulation in a...

Boston Scientific to present new data on advances in chronic pain...

Boston Scientific has announced key data that will be featured at the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA)....
in silico clinical trials

BRAIN 2021: In silico clinical trials likely to play complementary role...

In silico studies involving virtual participants hold great potential in the neurovascular field—and the broader medical industry—with their future role in the generation of...
aurora meta-analysis

AURORA: Evidence in favour of thrombectomy beyond six hours strengthened by...

Evidence favouring endovascular therapy (EVT) in anterior circulation stroke patients presenting with reversible cerebral ischaemia in the later time window (beyond six hours) from...

BlueWind Medical completes patient enrolment in OASIS study

BlueWind Medical has announced the successful completion of patient enrolment in the OASIS pivotal clinical study that will assess the company’s innovative Renova iStim...

Neuvotion secures more than US$1 million in seed funding to commercialise...

Neuvotion has announced that it has received more than US$1 million in seed funding. The Long Island Angel Network, an organised group of individual,...
evt neuroprotection

LINNC 2021: ESCAPE-NEXT trial may bring “dream” of combining neuroprotection with...

At this year’s LINNC Paris Course (14–16 September, Paris, France and virtual), audiences heard that the ESCAPE-NEXT trial (sponsored by NoNO Inc.), which has already started enrolling...
coating study phenox

ESMINT 2021: COATING study “badly needed” to assess surface modification of...

This year’s Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021; 8–10 September, Nice, France and virtual) saw details of the...
sensome clot out

Sensome begins first-in-human trial of AI-powered stroke guidewire

Sensome has announced enrolment of the first patients in the multicentre, first-in-human CLOT OUT study, which will evaluate the safety and performance of the...
flow diverter devices

“Welcome and exciting”: Evidence mounts in favour of flow diversion technologies

Multiple pieces of clinical research supporting the use of flow diverter devices to treat intracranial aneurysms have come to light so far in 2021....
swift-direct trial thrombectomy

Direct mechanical thrombectomy fails to show non-inferiority compared with IV t-PA...

The preliminary results of the SWIFT-DIRECT (Solitaire with the intention for thrombectomy plus IV t-PA versus direct Solitaire stent-retriever thrombectomy in acute anterior circulation...
ulf neuromodulation

Presidio Medical publishes clinical and preclinical research on ULF neuromodulation therapy

Presidio Medical has announced that research involving its novel ultra-low frequency (ULF) neuromodulation therapy has been published in Science Translational Medicine. The publication, titled...
synchron stentrode safety

Synchron announces US$10 million NIH grant for US COMMAND trial

The National Institutes of Health (NIH) has collectively awarded Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), Mount Sinai Health System and Synchron...
robocath stroke research

Robocath, Rennes University Hospital partner with Philips France to research stroke...

Robocath and Rennes University Hospital have announced they are launching a co-development research programme using robotics to improve treatments for stroke patients. With the...
virtual flow diverter trials

Flow diverter study with virtual participants “as effective as traditional clinical...

A study involving virtual participants—rather than real patients—was “as effective as traditional clinical trials” in evaluating the treatment of brain aneurysms using a flow...
covid causes disruption to clinical trials

COVID-19 causes “widespread disruption” to neuroendovascular research around the globe

“Widespread disruption of neuroendovascular trials occurred because of COVID-19,” conclude the investigators of a survey-based study examining the impact of the pandemic. Now, as...

Adapt clinical studies to alleviate impact of pandemic

A viewpoint in the Journal of the American Medical Association has offered potential solutions to modifying ongoing randomised clinical trials during the COVID-19 pandemic....